173 related articles for article (PubMed ID: 36110575)
1. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J
Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575
[TBL] [Abstract][Full Text] [Related]
2. Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients.
Zhang Y; Yue Q; Cao F; Li Y; Wei Y
Sci Rep; 2022 Jul; 12(1):11268. PubMed ID: 35787661
[TBL] [Abstract][Full Text] [Related]
3. A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer.
Jin Y; Li J; Tang C; He K; Shan D; Yan S; Deng G
Medicine (Baltimore); 2023 May; 102(18):e33664. PubMed ID: 37145007
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
Xiong Y; Kong X; Fang K; Sun G; Tu S; Wei Y; Ouyang Y; Wan R; Xiao W
Mol Biol Rep; 2023 Sep; 50(9):7405-7419. PubMed ID: 37452900
[TBL] [Abstract][Full Text] [Related]
5. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
6. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
7. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
[TBL] [Abstract][Full Text] [Related]
8. A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma.
Chen Y; Hu D; Wang F; Huang C; Xie H; Jin L
Aging (Albany NY); 2023 Nov; 15(21):12296-12313. PubMed ID: 37934582
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
[TBL] [Abstract][Full Text] [Related]
10. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
11. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
Front Genet; 2022; 13():833928. PubMed ID: 35330731
[No Abstract] [Full Text] [Related]
12. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
13. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma.
Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X
Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709
[TBL] [Abstract][Full Text] [Related]
17. A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients.
Kong X; Xiong Y
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12947-12964. PubMed ID: 37466792
[TBL] [Abstract][Full Text] [Related]
18. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
[TBL] [Abstract][Full Text] [Related]
19. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer.
Chen ZH; Lin YL; Chen SQ; Yang XY
World J Gastrointest Oncol; 2023 Nov; 15(11):1951-1973. PubMed ID: 38077636
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
Front Genet; 2022; 13():898507. PubMed ID: 35754846
[No Abstract] [Full Text] [Related]
[Next] [New Search]